Arriving in the field of obesity therapy, retatrutide represents a different method. Beyond many current medications, retatrutide functions as a double agonist, simultaneously affecting both GLP-like peptide-1 (GLP-1) and glucose-sensitive insulinotropic hormone (GIP) sensors. The concurrent activation fosters various helpful effects, including imp… Read More